Eaton Vance Management Abiomed Inc Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Abiomed Inc stock. As of the latest transaction made, Eaton Vance Management holds 126,759 shares of ABMD stock, worth $0. This represents 0.05% of its overall portfolio holdings.

Number of Shares

126,759

Previous 126,616 0.11%

Holding current value

Previous $31.3 Million 0.63%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $34,676 - $43,108	143 Added 0.11%	126,759 $31.1 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $207,875 - $313,242	-925 Reduced 0.73%	126,616 $31.3 Million
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $2.7 Million - $3.57 Million	9,741 Added 8.27%	127,541 $42.2 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $8,417 - $10,397	28 Added 0.02%	117,800 $42 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $2.54 Million - $3.08 Million	8,189 Added 7.47%	117,772 $38.1 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $149,219 - $199,464	568 Added 0.52%	109,583 $34.2 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $3.7 Million - $4.59 Million	12,927 Added 13.45%	109,015 $34.7 Million
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $6.14 Million - $7.9 Million	-24,379 Reduced 20.24%	96,088 $31.2 Million
Q3 2020 Nov 13, 2020	BUY	$255.22 - $317.0 $2.04 Million - $2.53 Million	7,986 Added 7.1%	120,467 $33.4 Million
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $2,969 - $5,398	21 Added 0.02%	112,481 $27.2 Million
Q1 2020 May 14, 2020	BUY	$130.51 - $196.01 $3.11 Million - $4.66 Million	23,795 Added 26.84%	112,460 $16.3 Million
Q4 2019 Feb 11, 2020	BUY	$159.31 - $223.54 $2,071 - $2,906	13 Added 0.01%	88,665 $15.1 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $1.35 Million - $2.14 Million	7,652 Added 9.45%	88,652 $15.8 Million
Q2 2019 Aug 16, 2019	BUY	$250.96 - $284.94 $19,072 - $21,655	76 Added 0.09%	81,000 $21.1 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $620,219 - $812,889	2,244 Added 2.85%	80,924 $23.1 Million
Q4 2018 Feb 07, 2019	BUY	$281.08 - $444.25 $5.27 Million - $8.33 Million	18,750 Added 31.29%	78,680 $25.6 Million
Q2 2018 Aug 10, 2018	BUY	$278.07 - $446.21 $1.9 Million - $3.05 Million	6,841 Added 12.89%	59,930 $24.5 Million
Q1 2018 May 07, 2018	BUY	$192.49 - $295.85 $665,245 - $1.02 Million	3,456 Added 6.96%	53,089 $15.4 Million
Q4 2017 Feb 12, 2018	BUY	$168.78 - $199.74 $888,120 - $1.05 Million	5,262 Added 11.86%	49,633 $9.3 Million
Q3 2017 Nov 13, 2017	BUY	$145.39 - $168.6 $6.45 Million - $7.48 Million	44,371	44,371 $7.48 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Abiomed Inc Transaction History